Funding Opportunities

SCN Infographic_Canada Map FINAL Bl

In March 2016 the Government of Canada provided an additional $12 million over two years to SCN to continue to support excellence and global leadership in translational stem cell research.

Over the next two years, ending March 31st, 2018 SCN will fund research and training needs through four strategic initiatives, specifically, three research funding programs and a training, outreach & workshop program.  All research proposals will be peer reviewed to ensure quality and scientific rigour and funding results will be based on peer review.

 

 


Impact Research Agreement Programs

Timelines:
May 16th – Call for Proposals Opens
June 22nd – Call for Proposals Closes (Midnight EDT)
Three types of Impact Research Agreements are being offered by SCN.

Clinical Translation Impact Research Agreements

are designed to support projects that develop novel cellular or therapeutic stem cell approaches to tissue repair and regeneration within specific disease models.  (Value: $100,000 for 1 year)
Download application form
View guidelines
Funding Applications must be emailed toscn.rcs2016@gmail.com

Commercialization Impact Research Agreements

are aimed at projects that generate novel technologies and intellectual property (IP) that have commercial value in the stem cell research or therapeutics markets. (Value: $100,000 for 1 year)
Download application form
View guidelines
Funding Applications must be emailed toscn.rcs2016@gmail.com

Public Policy Impact Research Agreements

are aimed at projects that will address public policy issues relevant to stem cell research. (Value: $50,000 for 1 year)
Download application form
View guidelines

Budget Template
Funding Applications must be emailed toscn.rcs2016@gmail.com

DISEASE TEAM RESEARCH AGREEMENTS

Timelines:
May 17th  –  Letters of Intent Period Opens
June 22nd –  Letters of Intent Period Closes (Midnight EDT)
November 4th  – Notification of Competition Results Issued

Disease Team Research Agreements support projects that are developing novel cellular or stem cell related therapeutic approaches to tissue repair and regeneration for specific diseases, possibly including; diabetes, heart disease, septic shock and lung disease.

Future research proposals must include multiple investigators with different expertise appropriate to the research project, thereby ensuring a multidisciplinary approach and bringing significant breadth and depth to the research project. SCN anticipates that an average of five HQP will participate on each project. (Value: $500,000 over two fiscal years)
Download letter of intent form
View guidelines
Funding Applications must be emailed toscn.rcs2016@gmail.com

CLINICAL TRIAL RESEARCH AGREEMENTS

Timelines:
May 17th  –  Letters of Intent Period Opens
June 22nd –  Letters of Intent Period Closes (Midnight EDT)
November 4th  –  Notification of Competition Results Issued

Clinical Trial Research Agreements are aimed at early stage clinical trials. Projects must have Health Canada approval and be at the patient recruitment stage. Grants will be awarded for projects that if successful will show the incremental benefit to the patient, as well as an economic analysis of the potential cost of treatment compared to current best available standard of care. (Value: $1 million over two fiscal years)
Download application form
View guidelines
Funding Applications must be emailed toscn.rcs2016@gmail.com

*Note: All research funding is subject to completion and approval of the SCN-Government of Canada Contribution Agreement for 2016-18.